Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...

TL;DR: The 'Dawn over Kovir' mod for The Witcher 3 is a prelude to The Witcher 4, letting players control Ciri as she becomes a Witcher. It's set in the region of Kovir and took some 800 hours to ...

Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...

(RTTNews) - SELLAS Life Sciences Group Inc. (SLS) reported that survival in its pivotal Phase 3 REGAL trial is extending longer than anticipated, delaying the occurrence of the 80th event required to ...

Zasocitinib showed superiority over placebo in phase 3 trials, achieving rapid and sustained skin clearance in plaque psoriasis. The trials demonstrated a favorable safety profile, with common adverse ...

GameSpot may get a commission from retail offers. In November, a modder going by the name Froddoyo released Project Misriah, which used Valve's Counter-Strike 2 as a medium to recreate Halo 3. The mod ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Scott Baird is a contributor with over a decade's experience writing about video games, along with board games and tabletop RPGs. Scott has previously worked for Dexerto, Cracked, Dorkly, and Gamepur.

Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now it can celebrate a key trial win for its first drug to gain an FDA approval in ...

The U.S. Space Force has selected SpaceX and United Launch Alliance to perform the first seven launches under the National Security Space Launch Program, or NSSL, Phase 3 Lane 2 contracts, Breaking ...

Based on prior, preclinical and clinical data, including 2 small randomized trials, I believe there is a high probability that Capricor Therapeutics' phase 3 trial will be positive. Topline results ...